AACR-CP: Gout Drug May Have Cancer Prevention Activity (CME/CE, with audio)

PHILADELPHIA (MedPage Today) — Levels of biomarkers associated with colon cancer declined significantly following treatment with the anti-gout drug allopurinol, although expression of the primary-endpoint marker did not change, according to a study reported here.

Post a Comment

Comments are closed.